Three-year data on world's smallest heart device show benefits of fixing holes in newborn hearts without surgery

Results reinforce that amplatzer piccolo™ occluder is safe and effective for closing an opening in the heart known as a "patent ductus arteriosus" (pda) in newborns study found low adverse event rates following a piccolo procedure, showing additional benefit of the device that can help babies avoid riskier surgery a pda is present in approximately 1 in 2,000 births1 abbott park, ill., sept. 8, 2022 /prnewswire/ -- abbott (nyse: abt) today announced three-year data showing the positive impact of the amplatzer piccolo™ occluder on treating babies (some weighing as little as two pounds) with a potentially life-threatening hole in the heart known as a patent ductus arteriosus (pda).
ABT Ratings Summary
ABT Quant Ranking